Abstract:Background: We have shown that L-748,337 (L-7), a selective β 3 -adrenergic receptor (AR) antagonist reversed LV dysfunction and β-AR desensitization in diabetes (DM) caused diabetic cardiomyopathy (DCM). The mechanism is unclear. Recent evidence suggests that normal myocardial performance depends on the balance in myocyte β 3 -, β 1 -, and β 2 -AR. Pivotal restructuring of β-AR system resulting in the decline of β-AR reserve plays a crucial role in DCM. We assessed the hypothesis that chronic L-7 would prevent DCM-induced abnormalities of β-AR subtype-stimulated regulation on intrinsic LV myocyte function and [Ca 2+ ] i regulation, thus restoring cardiac function. Methods: Studies were conducted in 3 groups of female mice: Type 2 DM (T2) (n=9), induced with high-fat diet (HFD) intake for 14 weeks (W), but after fed HFD for 4 W receiving streptozotocin (STZ, 40 mg/kg/day, i.p. for 5 days); T2/L-7 (n=7), T2 mice at 10 W received L-7 (10 -7 M/kg/day, mini-pump) for 4 W; and Controls (C)(n=9). We compared LV myocyte contractile and [Ca 2+ ] iT responses to β-AR subtype stimulation by random exposure of myocytes to Isoproterenol (ISO,10 -8 M) or a selective β 1 -, β 2 -, or β 3 -agonist, Norepinephrine (NE, 10 -7 M), Zinterol (ZIN, 10 -5 M) and BRL-37,344 (BRL, 10 -8 M), respectively, during drug perfusion. Results: T2 and T2/L-7 mice had mean blood glucose levels of 388 mg/dl and 369 mg/dl, respectively. Versus C, only in T2, basal LV myocyte contractility (dL/dt max , 76 vs 133 μm/s), relaxation and [Ca 2+ ] iT (0.16 vs 0.21) were significantly decreased. ISO-stimulated dL/dt max (40% vs 58%) was attenuated accompanied by a diminished NE-mediated increase in dL/dt max (28% vs 44%), but enhanced BRL-induced decreases in dL/dt max (29% vs 12%).The response of dL/dt max (24% vs 15%) to ZIN was increased. Importantly, in T2/L-7 myocytes, the basal dL/dt max (128 μm/s) and [Ca 2+ ] iT (0.21) remained close to control values with preserved β-stimulated positive modulation on cell contraction. The increases in dL/dt max in response to ISO (57%), NE (40%) or ZIN (15%) were similar to that in control myocytes, respectively. Conclusions: Chronic β 3 -AR antagonist reverses β-AR signaling defects, resensitizing the β-AR subtype system modulation on LV myocytes function, thus playing a salutary role in DCM.

L-DOPA cyclohexyl ester, an L-DOPA antagonist, protects neurostimmulated contractile response in mice heart

Opposite regulation by L-DOPA receptor GPR143 of the long and short forms of the dopamine D2 receptors

GPR143, an L-DOPA receptor, augments the ERK signaling via ADRA1B through coupling between GPR143 and ADRA1B

Inhibition of dystrophin breakdown and endothelial nitric-oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) in left ventricular hypertrophied Mice.

Effects of L-dopa on Cells Expressing D2 Receptors and Level of Dopamine Transmitter in Hemiparkinsonian Rats

Initial characterization of a transgenic mouse with overexpression of the human D1-dopamine receptor in the heart

Enhancement of Haloperidol-Induced Catalepsy by GPR143, an L-Dopa Receptor, in Striatal Cholinergic Interneurons

Nitric Oxide Regulation of Myocardial O-2 Consumption and Hep Metabolism

Intrarenal Dopamine Attenuates Deoxycorticosterone Acetate/High Salt–Induced Blood Pressure Elevation in Part Through Activation of a Medullary Cyclooxygenase 2 Pathway

Effects of Ono-1078, A Leukotriene Antagonist, on Cardiovascular-Responses Induced by Vagal-Stimulation, Capsaicin, and Substance-P in Guinea-Pigs

DP1 (Prostaglandin D2 Receptor 1) Activation Protects Against Vascular Remodeling and Vascular Smooth Muscle Cell Transition to Myofibroblasts in Angiotensin II–Induced Hypertension in Mice

Acetylcholinesterase inhibition prevents alterations in cardiovascular autonomic control and gastric motility in L-NAME-induced hypertensive rats

Alpha(1a)-Adrenergic Receptor Mediated Pressor Response To Phenylephrine In Anesthetized Rat

Abstract 9032: Restoration of Normal Cardiomyocyte Basal and β-Adrenergic Receptor (AR) Subtype Modulation in Diabetic Cardiomyopathy by Chronic Selective Beta3-AR Antagonist in a Mouse Model of Type 2 Diabetes

Evidence that the monoamine oxidase B (MAO-B) plays a central role in the inotropic dysfunction induced by genetic deletion of the Mas-related-G protein-coupled receptor D (MrgD) in mice

Potency of Catecholamines and Other L-Tyrosine Derivatives at the Cloned Mouse Adrenergic Receptors

Protective effect of adrenomedulin (13-52) on isoproterenol-induced myocardial injury in rats

Serotonergic Regulation of Synaptic Dopamine Levels Mitigates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease

Sympatho-inhibitory action of endogenous adrenomedullin through inhibition of oxidative stress in the brain

α 1A - adrenergic receptor mediated pressor response to phenylephrine in anesthetized rat

Modulation of left ventricular hypertrophy in spontaneously hypertensive rats by acetylcholinesterase and ACE inhibitors: physiological, biochemical, and proteomic studies